Design Therapeutics Inc.
(DSGN)
undefined
undefined%
At close: undefined
5.60
0.54%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | - | - | 226.00 | 834.00 |
Cost of Revenue | 537.00K | 466.00K | 129.00K | 5.00K | 1.65K |
Gross Profit | -537.00K | -466.00K | -129.00K | -4.77K | -820 |
Operating Income | -78.19M | -67.59M | -35.83M | -8.33M | -1.91M |
Interest Income | - | - | - | - | - |
Pretax Income | -66.86M | -63.31M | -35.53M | -8.28M | -2.05M |
Net Income | -66.86M | -58.62M | -35.53M | -8.28M | -2.05M |
Selling & General & Admin | 21.13M | 18.98M | 11.05M | 2.50M | 1.09M |
Research & Development | 57.06M | 48.61M | 24.78M | 6.06M | 1.65M |
Other Expenses | - | 4.29M | 298.00K | -226.00K | -834.00K |
Operating Expenses | 78.19M | 67.59M | 35.83M | 8.33M | 1.91M |
Interest Expense | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 78.19M | 67.59M | 35.83M | 8.33M | 1.91M |
Income Tax | -1 | -4.69M | -107.56K | -201.30K | -1.91K |
Shares Outstanding (Basic) | 55.98M | 55.71M | 45.94M | 27.19M | 27.19M |
Shares Outstanding (Diluted) | 55.98M | 55.71M | 45.94M | 27.19M | 27.19M |
EPS (Basic) | -1.19 | -1.05 | -0.77 | -0.3 | -0.08 |
EPS (Diluted) | -1.19 | -1.05 | -0.77 | -0.3 | -0.08 |
EBITDA | -66.33M | -62.84M | -35.70M | -8.32M | -139.00K |
Depreciation & Amortization | 537.00K | 466.00K | 129.00K | 5.00K | 1.91M |